Stimwave Technologies Announces Chris Valois as Director of Marketing and Strategy



POMPANO BEACH, Florida – (COMMERCIAL THREAD) – Today, Stimwave Technologies announced the appointment of Chris Valois as Director of Marketing and Strategy, effective January 1, 2022.

“We are delighted that Chris is joining our team in this newly created critical role. His leadership experience in the development of new therapies, strategic planning and business roles will be invaluable to our company’s growth trajectory. This is a key turning point in the continued commercialization of our innovative platforms for stimulating the spinal cord and peripheral nerves, ”said Aure Bruneau, Executive Director. “With many fundamental elements of our organization in place, we are now poised to further accelerate our collaboration with medical facilities, physicians and their teams to bring our therapy to the many other patients in need of chronic pain relief. We are confident that Chris will help take Stimwave Technologies to the next level.

Mr. Valois brings to the company more than two decades of leadership expertise in the medical technology industry, including extensive experience in product management, marketing and brand management. Above all, he has significant experience in neuromodulation technologies as well as minimally invasive solutions for the spine and orthopedic extremities. Most recently, he served as Managing Director of the US subsidiary of FH Ortho, which was recently acquired by Olympus. During his time there, Mr. Valois managed all areas of operations in the United States, with a focus on cross-functional collaboration, product launches and business excellence, with sustained and demonstrated business growth. . Chris was also Vice President of Sales and Marketing at Xtant Medical, where he led business operations and developed strategic initiatives for this orthobiology company. Previously, Mr. Valois held various positions of increasing responsibility at Tornier, which was later acquired by Wright Medical / Stryker, where he continued to work on the development of a long-term strategic plan and the formation of a marketing team for their growing portfolio. In addition, Mr. Valois held senior positions at Zimmer Biomet, St. Jude Medical and Medtronic after starting his career as an engineer. Mr. Valois holds a Bachelor of Science degree from the University of Wisconsin and a Master of Business Administration degree from the University of St. Thomas.

“I am very pleased to join the Stimwave Technologies team at this critical inflection point in our growth,” said Mr. Valois. “With cutting-edge technology, collaboration with market-leading physicians, strong clinical evidence and a compelling product portfolio, our Freedom therapies will positively evolve the way chronic pain is managed and will benefit many patients across the board. world. ”

Participation in the next industry conference

Stimwave Technologies will attend several upcoming industry conferences.

American Society of Pain and Neurosciences (ASPN) Advanced Lab and Data Disclosure

January 7-8, 2022

Las Vegas, Nevada

Table # 2 (Laboratory) Table # 18 (data disclosure)

North American Neuromodulation Society (NANS) 2022 Annual Meeting

January 13-15, 2022

Orlando florida

Booth # 704

About Stimwave Technologies, Inc.

Stimwave Technologies is a medical device company that develops, manufactures and markets neuromodulation products. Its Peripheral Nerve Stimulation (PNS) and Spinal Cord Stimulation (SCS) products are implanted technologies that block pain signals to the brain and provide a drug-free alternative for treating patients with chronic pain. Stimwave Technologies’ Freedom systems, SCS and PNS products, provide unique and innovative technology with wireless HF-EMC energy transfer from an external transmitter and antenna to the implanted electrode array and a separate receiver. Stimwave Technologies’ portfolio of FDA-approved products can treat the nerves in the neck that cause pain. Stimwave Technologies’ primary office is located in Pompano Beach, Florida, and operates worldwide through its operating subsidiaries. For more information, please visit



Comments are closed.